| For: | Reshetnyak VI, Maev IV. New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. World J Gastroenterol 2023; 29(37): 5292-5304 [PMID: 37899787 DOI: 10.3748/wjg.v29.i37.5292] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i37/5292.htm |
| Number | Citing Articles |
| 1 |
Vasiliy I Reshetnyak, Igor V Maev. Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. World Journal of Experimental Medicine 2025; 15(1): 101771 doi: 10.5493/wjem.v15.i1.101771
|
| 2 |
Hong-Li Liu, Xing Liu, Yi-Fan Hu, Xi-Xuan Wang, Yu Zhang, Li Wang, Sha-Sha Li, Yi-Jun Bao, Si-Wei Zheng, Qing-Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Huang, Xiao-Ning Feng, Wen-Quan Zeng, Cai-Yun Zhang, Kai Zhang, Yong-Feng Yang. Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04280-5
|
| 3 |
Vasiliy Ivanovich Reshetnyak, Elena Vladimirovna Vinnitskaya, Igor Veniaminovich Maev. Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. World Journal of Gastrointestinal Pathophysiology 2025; 16(2): 107347 doi: 10.4291/wjgp.v16.i2.107347
|
| 4 |
Armando Curto, Rocco G Iamello, Erica N Lynch, Andrea Galli. Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies. World Journal of Clinical Cases 2025; 13(30): 109028 doi: 10.12998/wjcc.v13.i30.109028
|
| 5 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(1028) |
Core Tip(989) |
Full Article(HTML)(4515)
|
Full Article with Cover (PDF)-1825K(349)
|
Full Article (Word)-130K(43)
|
Audio-14227K(29)
|
Peer-Review Report-222K(179)
|
Answering Reviewers-194K(126)
|
Full Article (PDF)-407K(264)
|
Full Article (XML)-119K(155)
|
Times Cited (0)
|
Total Visits (13818)
|
Open
|
| 6 |
Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guocai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng. Advances, challenges and future applications of liver organoids in experimental regenerative medicine. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1521851
|
| 7 |
Filippo Gabrielli, Eleonora Crepaldi, Alessia Cavicchioli, Marco Rivi, Arianna Carmen Costanzo, Carmela Cursaro, Pietro Andreone. Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments. Biomolecules 2024; 14(10): 1227 doi: 10.3390/biom14101227
|
| 8 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitis. Exploration of Immunology 2024; : 624 doi: 10.37349/ei.2024.00163
|
| 9 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. An Integrated Pathogenetic Model of Primary Biliary Cholangitis. Livers 2025; 5(2): 15 doi: 10.3390/livers5020015
|
| 10 |
Hengli Luo, Long Han, Kai He, Kun Chen, Qiming Wei, Chengbin Zhang, Longyang Jiang. Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization study. Medicine 2025; 104(40): e44873 doi: 10.1097/MD.0000000000044873
|
